Global Top 4 Companies Accounted for 52% of total Oral Proteins and Peptides market | |
Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention, treatment and diagnosis. Polypeptide is a compound formed by linking α-amino acids together with a peptide chain, and it is also an intermediate product of proteolysis. N polypeptide chains are entangled in a certain spatial structure to form a protein. The hydrolysis of macromolecular proteins produces polypeptides. Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment. The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc. Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc. The global key manufacturers of Oral Proteins and Peptides include Ironwood & Allergan (AbbVie), Novartis, etc. In 2021, the global top three players had a share approximately 52.0% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com | |
Target Prov.: All Provinces Target City : All Cities Last Update : May 13, 2024 3:18 AM Number of Views: 56 | Item Owner : Laura Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |